Abstract: A compound of Formula (1) or a pharmaceutically acceptable salt thereof: wherein R1 represents a C1-C6 alkyl group and R2 represents a C1-C6 alkyl group, while unlike a laxative, is effective in the treatment of constipation.

Abstract: Each of controllers includes: a transistor; a data processor for executing predetermined data processing and turning the transistor on or off in accordance with the data processing result; a pull-up resistor connected to an output terminal of the transistor; and a level separating resistor connected to the output terminal of the transistor, and the data processor of each controller detects a signal level of a control signal output from the output terminal of the transistor and judges whether or not any defect has occurred in its own controller, based on the detection result.

Abstract: Each of controllers includes: a transistor; a data processor for executing predetermined data processing and turning the transistor on or off in accordance with the data processing result; a pull-up resistor connected to an output terminal of the transistor; and a level separating resistor connected to the output terminal of the transistor, and the data processor of each controller detects a signal level of a control signal output from the output terminal of the transistor and judges whether or not any defect has occurred in its own controller, based on the detection result.

Abstract: The present invention provides a therapeutic and/or preventive agent for defecation dysfunction, which is suitable for continuous medication and comprises as an active ingredient a compound of Formula (1) or a pharmaceutically acceptable salt thereof: (wherein R1 represents a C1-C6 alkyl group and R2 represents a C1-C6 alkyl group). The above erythromycin derivative of Formula (1) has an improving effect on defecation dysfunction; and this improving effect on defecation dysfunction leads to acceleration of normal defecation, unlike a laxative. Further, the above compound of Formula (1) is also suitable for long-term clinical use because of its weaker antibacterial action than erythromycin. Thus, the present invention provides an agent having a safe and potent therapeutic and/or preventive effect on defecation dysfunction.

Abstract: A photographic camera having a camera body which is originally formatted for a film photography, i.e. the photography with a silver haloid film, and is selectively and detachably coupled with a camera back for the film photography (hereinafter referred to as a first camera back) and a camera back for digital photography with image pickup element or device, such as a CCD (hereinafter referred to as a second camera back). The camera body may adjusts photographic conditions in accordance with data of image pickup element mounted on the digital camera back. The camera body may alternatively which controls a range of photographic conditions in accordance with data of image pickup element mounted on the digital camera back.

Abstract: The present invention provides a system for making and publishing a homepage.

Abstract: An insoluble electrode structural material comprising a tabular or curved electrode base plate having at least one thin plate-form insoluble metal electrode detachably fixed to at least a part of the surface of the base plate.